XtalPi provides state-of-the-art crystal structure prediction (CSP, also known as polymorph prediction) technology that is pertinent throughout the drug development process and applicable across the biopharmaceutical industry. Combining quantum physics, artificial intelligence, and cloud HPC, XtalPi’s CSP technology offers reliable, highly accurate predictions for complex molecular systems within days to weeks, and provide crucial insights on important physicochemical characteristics of the drug molecule, which makes it the industry’s best solution for drug solid-state screening and designing.